MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodgers-Neame, N. T.
Right arrow Articles by Zorumski, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodgers-Neame, N. T.
Right arrow Articles by Zorumski, C. F.

Effects of a benz[e]indene on gamma-aminobutyric acid-gated chloride currents in cultured postnatal rat hippocampal neurons

NT Rodgers-Neame, DF Covey, Y Hu, KE Isenberg and CF Zorumski

Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri 63110.

Benz[e]indenes (BIs) are tricyclic molecules that can be envisioned as steroids without an A-ring. Because certain steroids are known to alter gamma-aminobutyric acid (GABA) responses in central neurons, we examined the effects of a substituted BI resembling 3 alpha-hydroxy-5 alpha-pregnan-20-one (3 alpha-OH-DHP) on GABA-gated chloride currents in cultured postnatal rat hippocampal neurons. The compound, BI-1, reversibly potentiated GABA currents at concentrations of > 10 nM, with an EC50 value of 0.2 microM. BI-1 increased the apparent affinity of GABA for its receptor, decreasing the GABA EC50 from 9 microM to 3 microM. BI-1 had no effect on the shape of the GABA current-voltage relationship and did not alter the GABA reversal potential. The effects of BI-1 were not altered by benzodiazepine or picrotoxin site antagonists. At concentrations up to 10 microM, where maximal effects on GABA currents were seen, BI-1 did not directly activate a membrane current. This contrasts with the effects of 3 alpha-OH-DHP, which activated chloride currents at concentrations that were subsaturating for GABA potentiation. These results suggest that the BIs may be useful for determining the mechanisms by which steroids potentiate GABA responses and directly gate chloride channels.

Volume 42, Issue 6, pp. 952-957, 12/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
P. Li, D. F. Covey, J. H. Steinbach, and G. Akk
Dual Potentiating and Inhibitory Actions of a Benz[e]indene Neurosteroid Analog on Recombinant {alpha}1beta2{gamma}2 GABAA Receptors
Mol. Pharmacol., June 1, 2006; 69(6): 2015 - 2026.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. M. Nakashima, S. M. Todorovic, D. F. Covey, and C. J. Lingle
The Anesthetic Steroid (+)-3alpha -Hydroxy-5alpha -androstane-17beta -carbonitrile Blocks N-, Q-, and R-Type, but Not L- and P-Type, High Voltage-Activated Ca2+ Current in Hippocampal and Dorsal Root Ganglion Neurons of the Rat
Mol. Pharmacol., September 1, 1998; 54(3): 559 - 568.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
K. L. Williams, J. B. Tucker, G. White, D. S. Weiss, J. A. Ferrendelli, D. F. Covey, J. E. Krause, and S. M. Rothman
Lactone Modulation of the gamma -Aminobutyric Acid A Receptor: Evidence for a Positive Modulatory Site
Mol. Pharmacol., July 1, 1997; 52(1): 114 - 119.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
S. Ueno, J. Bracamontes, C. Zorumski, D. S. Weiss, and J. H. Steinbach
Bicuculline and Gabazine Are Allosteric Inhibitors of Channel Opening of the GABAA Receptor
J. Neurosci., January 15, 1997; 17(2): 625 - 634.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics